Summary
Bone marrow cells from children with leukemia in remission and lymphoblasts and myeloblasts from children with early and late-stage leukemia all accumulated methotrexate during short-term culture and converted it to poly-γ-glutamyl derivatives. This metabolism was time and dose-dependent. Leukemia cells from two patients with chronic myelocytic leukemia also synthesized methotrexate polygluta-mates. Patients varied one from another in the quantity of total non-exchangeable methotrexate and methotrexate polyglutamates present in cells, but highest levels of each of these were seen in late acute lymphoblastic leukemia and in acute myeloblastic leukemia.
Co-incubation of leukemic cells with both methotrexate and a ten-fold excess of folinic acid decreased accumulation and poly-glutamylation of methotrexate to the same extent as chieved by reducing methotrexate concentration ten-fold. Co-incubation with methotrexate and a ten-fold excess of vincristine did not increase total cell methotrexate and methotrexate polyglutamates in leukemic cells in culture. Such an increase had been anticipated from earlier studiese with other cells. Indeed, levels of methotrexate and its derivatives were modestly reduced.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McBurney MW and Whitmore GF (1974) Cell 2: 182–188.
Taylor RT and Hanna ML (1977) Arch. Biochem. Biophys. 181:331–344.
Kisliuk RL, Gaumont Y and Baugh CM (1974) J. Biol. Chem. 249:4100–4103.
Coward JK, Paramaswaran KN, Cashmore AR and Bertino JR (1974) Biochem. 13:3899–3903.
Coward JK, Chello PL, Cashmore AR, Paramaswaran KN, De Angelis LM and Bertino JR (1975) Biochem. 14:1548–1552.
Bertino JR, Coward JK, Cashmore A, Chello P, Panichajakul S, Horvath CG and Stort RW (1976) Biochem. Soc. Transactions 4:853–856.
Dolnick BJ and Cheng YC (1978) J. Biol. Chem. 253:3563–3567.
Cheng YC, Szeto DW, Dolnick BJ, Rosowsky A, Cheng-Sein Y, Modest EJ, Piper JR, Temple Jr C, Elliot RD, Rose JD and Montgomery JA (1979) In Chemistry and Biology of Pteridines, Kisliuk and Brown (eds), Elsevier North Holland, Amsterdam, pp. 377–381.
Baggott JE and Krumdieck CL (1979) Biochem. 18:1036–1041.
McGuire JJ, Hsieh P, Coward JK and Bertino JR (1980) J. Biol. Chem. 255:5776–5788.
Baugh CM, Krumdieck CL and Nair MG (1973) Biochan. Biophys. Res. Commun. 52:27–34.
Nair MG and Baugh CM (1973) Biochan. 12 :3923–3927.
Whitehead VM (1973) Clin. Res. 21:655.
Brown JP, Davidson GE, Weir DG and Scott JM (1974) Int. J. Biochem: 5:727–733.
Shin YS, Buehring KU and Stokstad ELR (1974) J. Biol. Chem. 249:5772–5777.
Whitehead VM, Perrault MM and Stelcner S (1975) Cancer Res. 35:2985–2990.
Whitehead VM, Perrault MM and Stelcner S (1976) In Chemistry and Biology of Pteridines, W. Pfleiderer (ed), Walter de Gruyter, Berlin, pp. 475–483.
Jacobs SA, Adamson RH, Chabner BA, Derr CJ and Johns DG Biochem. Biophys. (1975) Res. Commun. 63:692–698.
Whitehead VM (1977) Cancer Res. 37:407–412.
Gewirtz DA, White JC, Randolph JK and Goldman ID (1979) Cancer Res. 39:2914–2918.
Gewirtz DA, White JC, Randolph JK and Goldman ID (1980) Cancer Res. 40:573–578.
Rosenblatt DS, Whitehead VM, Dupont MM, Vuchich MJ and Vera N (1978) Mol. Pharmacol. 14:210–214.
Rosenblatt DS, Whitehead VM, Vera N, Pottier A, Dupont MM and Vuchich MJ (1978) Mol. Pharmacol. 14:1143–1147.
Galivan J (1979) Cancer Res. 39:735–743.
Whitehead VM and Rosenblatt DS (1979) In Chemistry and Biology of Pteridines, Kisliuk RL and Brown GM (ed), Elsevier/North Holland, NY, pp. 689–694.
Schilsky RL, Bailey BD and Chabner BA (1980) Proc. Nat. Acad. Sci. 77:2919–2922.
Galivan J (1980) Mol. Pharmacol. 17:105–110.
Rosenblatt DS, Whitehead VM, Vuchich MJ, Pottier A, Matiaszuk NV and Beaulieu D (1981) Mol. Pharmacol. 19:87–97.
Jacobs SA, Derr JD and Johns DG (1977) Biochem. Pharmacol. 26:2310–2313.
Witte A, Whitehead VM, Rosenblatt DS and Vuchich MJ (1980) Dev. Pharmacol. Ther. 1:40–46.
Fyfe MJ and Goldman ID (1973) J. Biol. Chem. 248:5067–5073.
Rosenblatt DS and Whitehead VM Methotrexate polyglutamates in cultured human cells. This volume (supply reference please).
Goldman ID, Lichtenstein NS and Oliverio VT (1968) J. Biol. Chem. 243:5007–5017.
Goldman ID, Gupta V and White JC (1976) Cancer Res. 36:276–279.
Publication #81012 from the McGill University-Montreal Children’s Hospital Research Institute.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Whitehead, V.M., Rosenblatt, D.S. (1983). Methotrexate Metabolism by Bone Marrow Cells from Patients with Leukemia. In: Goldman, I.D., Chabner, B.A., Bertino, J.R. (eds) Folyl and Antifolyl Polyglutamates. Advances in Experimental Medicine and Biology, vol 163. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5241-0_22
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5241-0_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5243-4
Online ISBN: 978-1-4757-5241-0
eBook Packages: Springer Book Archive